文献速递系统性红斑狼疮

EB病毒血清学再激活与高危个体向系统性红斑狼疮转变的相关性

Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals.
PubMed 文献 · Ann Rheum Dis · 2019-06-19

研究纳入436例基线无SLE的SLE患者亲属,随访6.3年后56例(13%)转变为SLE。基线VCA IgG和EA IgG水平升高与向SLE转变相关(OR 1.28和1.43),且CD40和IL10基因变异与EBV抗体水平存在交互作用。

要点

  • SLE患者亲属中EBV血清学再激活与向SLE转变风险增加相关。
  • 基线VCA IgG和EA IgG升高与转变风险独立相关。
  • CD40和IL10基因变异与EBV抗体水平存在交互作用。

核心结论

  • EBV血清学再激活增强可增加未患病SLE亲属向SLE转变的概率。

研究设计与样本

  • 对436例基线无SLE的SLE患者亲属随访6.3(±3.9)年后重新评估,其中56例(13%)在随访前转变为SLE(累积≥4条ACR标准)。

主要发现

  • 转变者基线VCA IgG均值4.879±1.797 vs 自身抗体阴性未转变者3.866±1.795(p=0.0003),EA IgG均值1.192±1.113 vs 0.7774±0.8484(p=0.0236)。
  • VCA IgG升高与向SLE转变相关(OR 1.28,95%CI 1.07-1.53,p=0.007)。
  • EA IgG升高与向SLE转变相关(OR 1.43,95%CI 1.06-1.93,p=0.02)。
  • CD40变异rs48100485与VCA IgG水平、IL10变异rs3024493与VCA IgA水平在向SLE转变中存在显著交互作用。

关键数值与推荐

  • SLE转变定义为累积≥4条美国风湿病学会(ACR)标准。
  • VCA IgG转变OR 1.28(95%CI 1.07-1.53,p=0.007);EA IgG转变OR 1.43(95%CI 1.06-1.93,p=0.02)。

临床怎么用

  • 对SLE患者亲属可考虑监测EBV血清学抗体水平以评估转变风险。
  • EBV再激活相关宿主基因变异(CD40、IL10)可能有助于风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with unknown aetiology. Epstein-Barr virus (EBV) is an environmental factor associated with SLE. EBV maintains latency in B cells with frequent reactivation measured by antibodies against viral capsid antigen (VCA) and early antigen (EA). In this study, we determined whether EBV reactivation and single nucleotide polymorphisms (SNPs) in EBV-associated host genes are associated with SLE transition. METHODS: SLE patient relatives (n=436) who did not have SLE at baseline were recontacted after 6.3 (±3.9) years and evaluated for interim transitioning to SLE (≥4 cumulative American College of Rheumatology criteria); 56 (13%) transitioned to SLE prior to the follow-up visit. At both visits, detailed demographic, environmental, clinical information and blood samples were obtained. Antibodies against viral antigens were measured by ELISA. SNPs in IL10, CR2, TNFAIP3 and CD40 genes were typed by ImmunoChip. Generalised estimating equations were used to test associations between viral antibody levels and transitioning to SLE. RESULTS: Mean baseline VCA IgG (4.879±1.797 vs 3.866±1.795, p=0.0003) and EA IgG (1.192±1.113 vs 0.7774±0.8484, p=0.0236) levels were higher in transitioned compared with autoantibody negative non-transitioned relatives. Increased VCA IgG and EA IgG were associated with transitioning to SLE (OR 1.28 95% CI 1.07 to 1.53, p=0.007, OR 1.43 95% CI 1.06 to 1.93, p=0.02, respectively). Significant interactions were observed between CD40 variant rs48100485 and VCA IgG levels and IL10 variant rs3024493 and VCA IgA levels in transitioning to SLE. CONCLUSION: Heightened serologic reactivation of EBV increases the probability of transitioning to SLE in unaffected SLE relatives.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Jog NR, Young KA, Munroe ME, et al. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals. Ann Rheum Dis. 2019. PMID: 31217170. doi:10.1136/annrheumdis-2019-215361

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。